These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3307049)

  • 1. Effect of immunization with Escherichia coli J5 on graft-versus-host disease induced by minor histocompatibility antigens in mice.
    Moore RH; Lampert IA; Chia Y; Aber VR; Cohen J
    Transplantation; 1987 Aug; 44(2):249-53. PubMed ID: 3307049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of endotoxin on graft-versus-host disease after bone marrow transplantation across major histocompatibility barriers in mice.
    Moore RH; Lampert IA; Chia Y; Aber VR; Cohen J
    Transplantation; 1987 May; 43(5):731-6. PubMed ID: 3554664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic graft-versus-host disease induced by minor histocompatibility antigens in mice.
    Hamilton BL; Parkman R
    Transplantation; 1983 Aug; 36(2):150-5. PubMed ID: 6349039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.
    Marks MI; Ziegler EJ; Douglas H; Corbeil LB; Braude AI
    J Clin Invest; 1982 Apr; 69(4):742-9. PubMed ID: 7042755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of lethal graft-versus-host disease: transplantation of cultured murine bone marrow across minor histocompatibility differences.
    Mauch P; Lipton JM; Hamilton BL; Obbagy J; Nathan D; Hellman S
    Blood; 1985 Sep; 66(3):542-7. PubMed ID: 3896345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
    Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
    Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia.
    Braude AI; Ziegler EJ; Douglas H; McCutchan JA
    J Infect Dis; 1977 Aug; 136 Suppl():S167-73. PubMed ID: 330776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.
    Fenwick BW; Cullor JS; Osburn BI; Olander HJ
    Infect Immun; 1986 Aug; 53(2):298-304. PubMed ID: 3525407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of GVHD across classical, single minor histocompatibiliTy (miH) locus barriers in mice.
    Blazar BR; Roopenian DC; Taylor PA; Christianson GJ; Panoskaltsis-Mortari A; Vallera DA
    Transplantation; 1996 Feb; 61(4):619-24. PubMed ID: 8610390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
    Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody titres to a rough-mutant strain of Escherichia coli in patients undergoing allogeneic bone-marrow transplantation. Evidence of a protective effect against graft-versus-host disease.
    Cohen J; Moore RH; Al Hashimi S; Jones L; Apperley JF; Aber VR
    Lancet; 1987 Jan; 1(8523):8-11. PubMed ID: 2879147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of graft-versus-host disease using antibody to Thy 1. A role for complement in vivo.
    Hamilton BL; Harris D
    Transplantation; 1985 Jul; 40(1):90-6. PubMed ID: 2861676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.
    Ziegler EJ; McCutchan JA; Fierer J; Glauser MP; Sadoff JC; Douglas H; Braude AI
    N Engl J Med; 1982 Nov; 307(20):1225-30. PubMed ID: 6752708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5.
    Baumgartner JD; Heumann D; Calandra T; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):769-72. PubMed ID: 2010630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
    Halle-Pannenko O; Pritchard LL; Rappaport H
    Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras abrogates lethal GVHD while preserving GVL effect.
    de la Selle V; Miconnet I; Gilbert D; Bruley-Rosset M
    Bone Marrow Transplant; 1995 Jul; 16(1):111-8. PubMed ID: 7581109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of dairy cows with an Escherichia coli J5 lipopolysaccharide vaccine.
    Tomita GM; Todhunter DA; Hogan JS; Smith KL
    J Dairy Sci; 1995 Oct; 78(10):2178-85. PubMed ID: 8598402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis.
    Cross AS; Opal SM; Warren HS; Palardy JE; Glaser K; Parejo NA; Bhattacharjee AK
    J Infect Dis; 2001 Apr; 183(7):1079-86. PubMed ID: 11237833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.